⌘K
Loading ticker…
As of 2026-08-24, Journey Medical Corporation Common Stock (DERM) has a 3-month relative strength percentile of 89 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.1%, relative volume 0.67×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
DERM is held by 9 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $666K notional. Top 3 carry $846K.
Held by 15 ETFs · $9M across latest filings · largest weight 0.31% (QQQS).
Top 9 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.00% | $666K | — |
| VTWG | 0.01% | $121K | — |
| QQQS | 0.31% | $59K | −0.16 pp |
| VTHRVanguard Russell 3000 ETF | 0.00% | $9K | — |
| ITWO | 0.00% | $6K | — |
| URTY | 0.00% | $5K | — |
| UWM | 0.00% | $5K | — |
| HDG | 0.00% | $120 | — |
| RB | 0.00% | $32 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DERM Jan avg: 7.07% median: 12.40% win: 75% σ: 15.92% n: 4 2022-04-12 → 2026-07-31 | DERM Feb avg: -6.04% median: -10.42% win: 25% σ: 22.36% n: 4 2022-04-12 → 2026-07-31 | DERM Mar avg: -12.66% median: -6.41% win: 25% σ: 20.65% n: 4 2022-04-12 → 2026-07-31 | DERM Apr avg: 4.76% median: 9.81% win: 80% σ: 17.64% n: 5 2022-04-12 → 2026-07-31 | DERM May avg: 1.29% median: 5.69% win: 80% σ: 19.76% n: 5 2022-04-12 → 2026-07-31 | DERM Jun avg: 15.12% median: 12.20% win: 60% σ: 23.56% n: 5 2022-04-12 → 2026-07-31 | DERM Jul avg: 2.37% median: -0.27% win: 40% σ: 11.60% n: 5 2022-04-12 → 2026-07-31 | DERM Aug avg: -2.62% median: -5.55% win: 25% σ: 9.74% n: 4 2022-04-12 → 2026-07-31 (current) | DERM Sep avg: 3.22% median: 6.10% win: 50% σ: 23.64% n: 4 2022-04-12 → 2026-07-31 | DERM Oct avg: 7.75% median: 7.91% win: 75% σ: 14.09% n: 4 2022-04-12 → 2026-07-31 | DERM Nov avg: 1.47% median: -0.05% win: 50% σ: 18.85% n: 4 2022-04-12 → 2026-07-31 | DERM Dec avg: 1.19% median: 1.10% win: 50% σ: 27.83% n: 4 2022-04-12 → 2026-07-31 |